市場調査レポート
商品コード
1309726

血栓症および止血バイオマーカーの世界市場規模、シェア、産業動向分析レポート:製品別、用途別、最終用途別、所在地別、タイプ別、地域別展望と予測、2023年~2030年

Global Thrombosis And Hemostasis Biomarkers Market Size, Share & Industry Trends Analysis Report By Product, By Application, By End-use, By Location, By Type, By Regional Outlook and Forecast, 2023 - 2030

出版日: | 発行: KBV Research | ページ情報: 英文 347 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.09円
血栓症および止血バイオマーカーの世界市場規模、シェア、産業動向分析レポート:製品別、用途別、最終用途別、所在地別、タイプ別、地域別展望と予測、2023年~2030年
出版日: 2023年06月30日
発行: KBV Research
ページ情報: 英文 347 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

血栓症および止血バイオマーカー市場規模は2030年までに74億米ドルに達し、予測期間中のCAGRは5.6%で上昇すると予測されています。

しかし、止血や損傷の大きい症例への対応については、医師をはじめとする医療関係者の間で議論が続いています。止血剤単体では、過度の出血を引き起こすような大きな傷害を負った場合にあまり役に立たないです。したがって、今後数年間は、これらの要因が市場の成長を阻害する可能性があります。

製品の展望

製品によって、市場は分析装置と試薬・消耗品に分類されます。試薬・消耗品セグメントは2022年の市場で最も高い収益シェアを獲得しました。診断ツールに対する大きなニーズ、凝固・出血性疾患の有病率の上昇、最近の製品イントロダクションなどが、このセグメントの市場優位性の要因となっています。予測期間を通じて、試薬および消耗品セグメントは大幅に増加すると予測されます。

場所の展望

場所は、臨床検査室検査とポイントオブケア検査に分類されます。2022年の市場では、ポイントオブケア検査分野が大きな収益シェアを記録しました。POC検査はわずか数分で答えを出すことができるため、ヘルスケア従事者にとって便利です。POCTは、医院やER、あるいは患者の自宅など、従来の臨床検査室以外の場所でも診断検査を実施できるようにするもので、市場を牽引しています。

タイプ別展望

タイプ別では、Dダイマー、抗トロンビンIII、プラスミノーゲン&フィブリノーゲン、可溶性フィブリン、セレクチン、第VIII因子、PT、APTT、その他に分類されます。ポストトロンビン(PT)セグメントは、2022年の市場で最大の収益シェアを示しました。この検査は、血栓を止めることを目的としたワルファリンなどの抗凝固薬がどの程度効いているかを追跡することを可能にします。さらに、肝臓の病気や血液疾患の診断にも使用されます。血液希釈剤を使用していない人の場合、血漿が凝固するのに通常11~13.5秒かかります。

用途の展望

用途に基づき、市場は深部静脈血栓症(DVT)、肺塞栓症(PE)、播種性血管内凝固症候群(DIC)、その他に区分されます。肺塞栓症(PE)セグメントは、2022年の市場で大きな収益シェアを示しました。肺の血管に血栓ができると、腕や脚など他の部位にも血栓ができ、肺塞栓症として知られる状態になります。肺塞栓症は、心臓発作、脳卒中に次いで第3位であり、心血管疾患の中で最も蔓延している疾患の一つです。例えば、米国肺協会は、2023年1月現在、毎年約90万人の米国人がPEに罹患していると推定しています。

最終用途の展望

最終用途別に見ると、市場は病院・診療所、学術・研究機関、診断センター、その他に分類されます。診断センター部門は、2022年の市場で最大の収益シェアを獲得しました。病院が検査や評価のために診断センターに依存する傾向が強まっていることがこのシェアの要因となっており、これがこのセグメントの急速な拡大をさらに後押ししています。診断検査の払い戻しなど、さまざまなアメニティを提供する政府のイニシアチブの拡大は、業界の成長を促進すると予想されるもう1つの重要な要素です。

地域別展望

地域別に見ると、市場は北米、欧州、アジア太平洋、LAMEAで分析されます。北米セグメントは2022年の市場で最大の収益シェアを獲得しました。血栓症・止血障害の頻度上昇、技術新興国市場の開拓、血栓症および止血バイオマーカーの研究開発の進行が、この地域の市場を推進する主な要因です。例として、米国疾病予防管理センターによると、米国における静脈血栓塞栓症(VTE)の年間死亡予測は6万~10万人です。

目次

第1章 市場範囲と調査手法

  • 市場の定義
  • 目的
  • 市場範囲
  • セグメンテーション
  • 調査手法

第2章 市場概要

  • イントロダクション
    • 概要
      • 市場構成とシナリオ
  • 市場に影響を与える主な要因
    • 市場促進要因
    • 市場抑制要因

第3章 世界の血栓症および止血バイオマーカー市場:製品別

  • 世界の試薬および消耗品市場:地域別
  • 世界の分析装置市場:地域別

第4章 世界の血栓症および止血バイオマーカー市場:用途別

  • 世界の深部静脈血栓症(DVT)市場:地域別
  • 世界の肺塞栓症(PE)市場:地域別
  • 世界の播種性血管内凝固症候群(DIC)およびその他の市場:地域別

第5章 世界の血栓症および止血バイオマーカー市場:最終用途別

  • 世界の診断センター市場:地域別
  • 世界の病院およびクリニック市場:地域別
  • 世界の学術調査機関およびその他の市場:地域別

第6章 世界の血栓症および止血バイオマーカー市場:所在地別

  • 世界の臨床検査市場:地域別
  • 世界のポイントオブケア検査市場:地域別

第7章 世界の血栓症および止血バイオマーカー市場:タイプ別

  • 世界のポストトロンビン(PT)市場:地域別
  • 世界の活性化部分トロンボプラスチン時間(APTT)検査市場:地域別
  • 世界のD-ダイマー市場:地域別
  • 世界のアンチトロンビンIII市場:地域別
  • 世界のプラスミノーゲンおよびフィブリノーゲン市場:地域別
  • 世界の可溶性フィブリン市場:地域別
  • 世界のセレクチン市場:地域別
  • 世界の第VIII因子市場:地域別
  • 世界のその他の市場:地域別

第8章 世界の血栓症および止血バイオマーカー市場:地域別

  • 北米
    • 北米の市場:国別
      • 米国
      • カナダ
      • メキシコ
      • その他北米地域
  • 欧州
    • 欧州の市場:国別
      • ドイツ
      • 英国
      • フランス
      • ロシア
      • スペイン
      • イタリア
      • その他欧州地域
  • アジア太平洋
    • アジア太平洋の市場:国別
      • 中国
      • 日本
      • インド
      • 韓国
      • シンガポール
      • マレーシア
      • その他アジア太平洋地域
  • ラテンアメリカ・中東・アフリカ
    • ラテンアメリカ・中東・アフリカの市場:国別
      • ブラジル
      • アルゼンチン
      • アラブ首長国連邦
      • サウジアラビア
      • 南アフリカ
      • ナイジェリア
      • その他ラテンアメリカ・中東・アフリカ地域

第9章 企業プロファイル

  • Thermo Fisher Scientific, Inc
  • F Hoffmann-La Roche Ltd.
  • Siemens Healthineers AG(Siemens AG)
  • Abbott Laboratories
  • BioMerieux SA
  • Horiba Ltd
  • QuidelOrtho Corporation
  • Werfen, SA
  • Diazyme Laboratories, Inc(General Atomics)
  • BioMedica Diagnostics Inc(Scotia Investments Family of Companies)
図表

LIST OF TABLES

  • TABLE 1 Global Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
  • TABLE 2 Global Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
  • TABLE 3 Global Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
  • TABLE 4 Global Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
  • TABLE 5 Global Reagents & Consumables Market by Region, 2019 - 2022, USD Million
  • TABLE 6 Global Reagents & Consumables Market by Region, 2023 - 2030, USD Million
  • TABLE 7 Global Analyzers Market by Region, 2019 - 2022, USD Million
  • TABLE 8 Global Analyzers Market by Region, 2023 - 2030, USD Million
  • TABLE 9 Global Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
  • TABLE 10 Global Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
  • TABLE 11 Global Deep Vein Thrombosis (DVT) Market by Region, 2019 - 2022, USD Million
  • TABLE 12 Global Deep Vein Thrombosis (DVT) Market by Region, 2023 - 2030, USD Million
  • TABLE 13 Global Pulmonary Embolism (PE) Market by Region, 2019 - 2022, USD Million
  • TABLE 14 Global Pulmonary Embolism (PE) Market by Region, 2023 - 2030, USD Million
  • TABLE 15 Global Disseminated Intravascular Coagulation (DIC) & Others Market by Region, 2019 - 2022, USD Million
  • TABLE 16 Global Disseminated Intravascular Coagulation (DIC) & Others Market by Region, 2023 - 2030, USD Million
  • TABLE 17 Global Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
  • TABLE 18 Global Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
  • TABLE 19 Global Diagnostic Centers Market by Region, 2019 - 2022, USD Million
  • TABLE 20 Global Diagnostic Centers Market by Region, 2023 - 2030, USD Million
  • TABLE 21 Global Hospitals & Clinics Market by Region, 2019 - 2022, USD Million
  • TABLE 22 Global Hospitals & Clinics Market by Region, 2023 - 2030, USD Million
  • TABLE 23 Global Academic & Research Institutes and Others Market by Region, 2019 - 2022, USD Million
  • TABLE 24 Global Academic & Research Institutes and Others Market by Region, 2023 - 2030, USD Million
  • TABLE 25 Global Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
  • TABLE 26 Global Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
  • TABLE 27 Global Clinical Laboratory Tests Market by Region, 2019 - 2022, USD Million
  • TABLE 28 Global Clinical Laboratory Tests Market by Region, 2023 - 2030, USD Million
  • TABLE 29 Global Point-of-Care Tests Market by Region, 2019 - 2022, USD Million
  • TABLE 30 Global Point-of-Care Tests Market by Region, 2023 - 2030, USD Million
  • TABLE 31 Global Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
  • TABLE 32 Global Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
  • TABLE 33 Global Post-Thrombin (PT) Market by Region, 2019 - 2022, USD Million
  • TABLE 34 Global Post-Thrombin (PT) Market by Region, 2023 - 2030, USD Million
  • TABLE 35 Global Activated Partial Thromboplastin Time (APTT) Test Market by Region, 2019 - 2022, USD Million
  • TABLE 36 Global Activated Partial Thromboplastin Time (APTT) Test Market by Region, 2023 - 2030, USD Million
  • TABLE 37 Global D-Dimer Market by Region, 2019 - 2022, USD Million
  • TABLE 38 Global D-Dimer Market by Region, 2023 - 2030, USD Million
  • TABLE 39 Global Anti-Thrombin III Market by Region, 2019 - 2022, USD Million
  • TABLE 40 Global Anti-Thrombin III Market by Region, 2023 - 2030, USD Million
  • TABLE 41 Global Plasminogen & Fibrinogen Market by Region, 2019 - 2022, USD Million
  • TABLE 42 Global Plasminogen & Fibrinogen Market by Region, 2023 - 2030, USD Million
  • TABLE 43 Global Soluble Fibrin Market by Region, 2019 - 2022, USD Million
  • TABLE 44 Global Soluble Fibrin Market by Region, 2023 - 2030, USD Million
  • TABLE 45 Global Selectins Market by Region, 2019 - 2022, USD Million
  • TABLE 46 Global Selectins Market by Region, 2023 - 2030, USD Million
  • TABLE 47 Global Factor VIII Market by Region, 2019 - 2022, USD Million
  • TABLE 48 Global Factor VIII Market by Region, 2023 - 2030, USD Million
  • TABLE 49 Global Others Market by Region, 2019 - 2022, USD Million
  • TABLE 50 Global Others Market by Region, 2023 - 2030, USD Million
  • TABLE 51 Global Thrombosis And Hemostasis Biomarkers Market by Region, 2019 - 2022, USD Million
  • TABLE 52 Global Thrombosis And Hemostasis Biomarkers Market by Region, 2023 - 2030, USD Million
  • TABLE 53 North America Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
  • TABLE 54 North America Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
  • TABLE 55 North America Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
  • TABLE 56 North America Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
  • TABLE 57 North America Reagents & Consumables Market by Country, 2019 - 2022, USD Million
  • TABLE 58 North America Reagents & Consumables Market by Country, 2023 - 2030, USD Million
  • TABLE 59 North America Analyzers Market by Country, 2019 - 2022, USD Million
  • TABLE 60 North America Analyzers Market by Country, 2023 - 2030, USD Million
  • TABLE 61 North America Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
  • TABLE 62 North America Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
  • TABLE 63 North America Deep Vein Thrombosis (DVT) Market by Country, 2019 - 2022, USD Million
  • TABLE 64 North America Deep Vein Thrombosis (DVT) Market by Country, 2023 - 2030, USD Million
  • TABLE 65 North America Pulmonary Embolism (PE) Market by Country, 2019 - 2022, USD Million
  • TABLE 66 North America Pulmonary Embolism (PE) Market by Country, 2023 - 2030, USD Million
  • TABLE 67 North America Disseminated Intravascular Coagulation (DIC) & Others Market by Country, 2019 - 2022, USD Million
  • TABLE 68 North America Disseminated Intravascular Coagulation (DIC) & Others Market by Country, 2023 - 2030, USD Million
  • TABLE 69 North America Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
  • TABLE 70 North America Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
  • TABLE 71 North America Diagnostic Centers Market by Country, 2019 - 2022, USD Million
  • TABLE 72 North America Diagnostic Centers Market by Country, 2023 - 2030, USD Million
  • TABLE 73 North America Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
  • TABLE 74 North America Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
  • TABLE 75 North America Academic & Research Institutes and Others Market by Country, 2019 - 2022, USD Million
  • TABLE 76 North America Academic & Research Institutes and Others Market by Country, 2023 - 2030, USD Million
  • TABLE 77 North America Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
  • TABLE 78 North America Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
  • TABLE 79 North America Clinical Laboratory Tests Market by Country, 2019 - 2022, USD Million
  • TABLE 80 North America Clinical Laboratory Tests Market by Country, 2023 - 2030, USD Million
  • TABLE 81 North America Point-of-Care Tests Market by Country, 2019 - 2022, USD Million
  • TABLE 82 North America Point-of-Care Tests Market by Country, 2023 - 2030, USD Million
  • TABLE 83 North America Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
  • TABLE 84 North America Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
  • TABLE 85 North America Post-Thrombin (PT) Market by Country, 2019 - 2022, USD Million
  • TABLE 86 North America Post-Thrombin (PT) Market by Country, 2023 - 2030, USD Million
  • TABLE 87 North America Activated Partial Thromboplastin Time (APTT) Test Market by Country, 2019 - 2022, USD Million
  • TABLE 88 North America Activated Partial Thromboplastin Time (APTT) Test Market by Country, 2023 - 2030, USD Million
  • TABLE 89 North America D-Dimer Market by Country, 2019 - 2022, USD Million
  • TABLE 90 North America D-Dimer Market by Country, 2023 - 2030, USD Million
  • TABLE 91 North America Anti-Thrombin III Market by Country, 2019 - 2022, USD Million
  • TABLE 92 North America Anti-Thrombin III Market by Country, 2023 - 2030, USD Million
  • TABLE 93 North America Plasminogen & Fibrinogen Market by Country, 2019 - 2022, USD Million
  • TABLE 94 North America Plasminogen & Fibrinogen Market by Country, 2023 - 2030, USD Million
  • TABLE 95 North America Soluble Fibrin Market by Country, 2019 - 2022, USD Million
  • TABLE 96 North America Soluble Fibrin Market by Country, 2023 - 2030, USD Million
  • TABLE 97 North America Selectins Market by Country, 2019 - 2022, USD Million
  • TABLE 98 North America Selectins Market by Country, 2023 - 2030, USD Million
  • TABLE 99 North America Factor VIII Market by Country, 2019 - 2022, USD Million
  • TABLE 100 North America Factor VIII Market by Country, 2023 - 2030, USD Million
  • TABLE 101 North America Others Market by Country, 2019 - 2022, USD Million
  • TABLE 102 North America Others Market by Country, 2023 - 2030, USD Million
  • TABLE 103 North America Thrombosis And Hemostasis Biomarkers Market by Country, 2019 - 2022, USD Million
  • TABLE 104 North America Thrombosis And Hemostasis Biomarkers Market by Country, 2023 - 2030, USD Million
  • TABLE 105 US Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
  • TABLE 106 US Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
  • TABLE 107 US Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
  • TABLE 108 US Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
  • TABLE 109 US Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
  • TABLE 110 US Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
  • TABLE 111 US Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
  • TABLE 112 US Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
  • TABLE 113 US Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
  • TABLE 114 US Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
  • TABLE 115 US Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
  • TABLE 116 US Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
  • TABLE 117 Canada Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
  • TABLE 118 Canada Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
  • TABLE 119 Canada Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
  • TABLE 120 Canada Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
  • TABLE 121 Canada Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
  • TABLE 122 Canada Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
  • TABLE 123 Canada Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
  • TABLE 124 Canada Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
  • TABLE 125 Canada Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
  • TABLE 126 Canada Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
  • TABLE 127 Canada Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
  • TABLE 128 Canada Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
  • TABLE 129 Mexico Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
  • TABLE 130 Mexico Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
  • TABLE 131 Mexico Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
  • TABLE 132 Mexico Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
  • TABLE 133 Mexico Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
  • TABLE 134 Mexico Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
  • TABLE 135 Mexico Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
  • TABLE 136 Mexico Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
  • TABLE 137 Mexico Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
  • TABLE 138 Mexico Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
  • TABLE 139 Mexico Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
  • TABLE 140 Mexico Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
  • TABLE 141 Rest of North America Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
  • TABLE 142 Rest of North America Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
  • TABLE 143 Rest of North America Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
  • TABLE 144 Rest of North America Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
  • TABLE 145 Rest of North America Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
  • TABLE 146 Rest of North America Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
  • TABLE 147 Rest of North America Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
  • TABLE 148 Rest of North America Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
  • TABLE 149 Rest of North America Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
  • TABLE 150 Rest of North America Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
  • TABLE 151 Rest of North America Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
  • TABLE 152 Rest of North America Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
  • TABLE 153 Europe Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
  • TABLE 154 Europe Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
  • TABLE 155 Europe Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
  • TABLE 156 Europe Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
  • TABLE 157 Europe Reagents & Consumables Market by Country, 2019 - 2022, USD Million
  • TABLE 158 Europe Reagents & Consumables Market by Country, 2023 - 2030, USD Million
  • TABLE 159 Europe Analyzers Market by Country, 2019 - 2022, USD Million
  • TABLE 160 Europe Analyzers Market by Country, 2023 - 2030, USD Million
  • TABLE 161 Europe Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
  • TABLE 162 Europe Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
  • TABLE 163 Europe Deep Vein Thrombosis (DVT) Market by Country, 2019 - 2022, USD Million
  • TABLE 164 Europe Deep Vein Thrombosis (DVT) Market by Country, 2023 - 2030, USD Million
  • TABLE 165 Europe Pulmonary Embolism (PE) Market by Country, 2019 - 2022, USD Million
  • TABLE 166 Europe Pulmonary Embolism (PE) Market by Country, 2023 - 2030, USD Million
  • TABLE 167 Europe Disseminated Intravascular Coagulation (DIC) & Others Market by Country, 2019 - 2022, USD Million
  • TABLE 168 Europe Disseminated Intravascular Coagulation (DIC) & Others Market by Country, 2023 - 2030, USD Million
  • TABLE 169 Europe Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
  • TABLE 170 Europe Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
  • TABLE 171 Europe Diagnostic Centers Market by Country, 2019 - 2022, USD Million
  • TABLE 172 Europe Diagnostic Centers Market by Country, 2023 - 2030, USD Million
  • TABLE 173 Europe Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
  • TABLE 174 Europe Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
  • TABLE 175 Europe Academic & Research Institutes and Others Market by Country, 2019 - 2022, USD Million
  • TABLE 176 Europe Academic & Research Institutes and Others Market by Country, 2023 - 2030, USD Million
  • TABLE 177 Europe Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
  • TABLE 178 Europe Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
  • TABLE 179 Europe Clinical Laboratory Tests Market by Country, 2019 - 2022, USD Million
  • TABLE 180 Europe Clinical Laboratory Tests Market by Country, 2023 - 2030, USD Million
  • TABLE 181 Europe Point-of-Care Tests Market by Country, 2019 - 2022, USD Million
  • TABLE 182 Europe Point-of-Care Tests Market by Country, 2023 - 2030, USD Million
  • TABLE 183 Europe Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
  • TABLE 184 Europe Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
  • TABLE 185 Europe Post-Thrombin (PT) Market by Country, 2019 - 2022, USD Million
  • TABLE 186 Europe Post-Thrombin (PT) Market by Country, 2023 - 2030, USD Million
  • TABLE 187 Europe Activated Partial Thromboplastin Time (APTT) Test Market by Country, 2019 - 2022, USD Million
  • TABLE 188 Europe Activated Partial Thromboplastin Time (APTT) Test Market by Country, 2023 - 2030, USD Million
  • TABLE 189 Europe D-Dimer Market by Country, 2019 - 2022, USD Million
  • TABLE 190 Europe D-Dimer Market by Country, 2023 - 2030, USD Million
  • TABLE 191 Europe Anti-Thrombin III Market by Country, 2019 - 2022, USD Million
  • TABLE 192 Europe Anti-Thrombin III Market by Country, 2023 - 2030, USD Million
  • TABLE 193 Europe Plasminogen & Fibrinogen Market by Country, 2019 - 2022, USD Million
  • TABLE 194 Europe Plasminogen & Fibrinogen Market by Country, 2023 - 2030, USD Million
  • TABLE 195 Europe Soluble Fibrin Market by Country, 2019 - 2022, USD Million
  • TABLE 196 Europe Soluble Fibrin Market by Country, 2023 - 2030, USD Million
  • TABLE 197 Europe Selectins Market by Country, 2019 - 2022, USD Million
  • TABLE 198 Europe Selectins Market by Country, 2023 - 2030, USD Million
  • TABLE 199 Europe Factor VIII Market by Country, 2019 - 2022, USD Million
  • TABLE 200 Europe Factor VIII Market by Country, 2023 - 2030, USD Million
  • TABLE 201 Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 202 Europe Others Market by Country, 2023 - 2030, USD Million
  • TABLE 203 Europe Thrombosis And Hemostasis Biomarkers Market by Country, 2019 - 2022, USD Million
  • TABLE 204 Europe Thrombosis And Hemostasis Biomarkers Market by Country, 2023 - 2030, USD Million
  • TABLE 205 Germany Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
  • TABLE 206 Germany Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
  • TABLE 207 Germany Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
  • TABLE 208 Germany Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
  • TABLE 209 Germany Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
  • TABLE 210 Germany Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
  • TABLE 211 Germany Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
  • TABLE 212 Germany Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
  • TABLE 213 Germany Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
  • TABLE 214 Germany Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
  • TABLE 215 Germany Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
  • TABLE 216 Germany Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
  • TABLE 217 UK Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
  • TABLE 218 UK Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
  • TABLE 219 UK Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
  • TABLE 220 UK Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
  • TABLE 221 UK Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
  • TABLE 222 UK Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
  • TABLE 223 UK Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
  • TABLE 224 UK Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
  • TABLE 225 UK Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
  • TABLE 226 UK Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
  • TABLE 227 UK Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
  • TABLE 228 UK Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
  • TABLE 229 France Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
  • TABLE 230 France Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
  • TABLE 231 France Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
  • TABLE 232 France Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
  • TABLE 233 France Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
  • TABLE 234 France Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
  • TABLE 235 France Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
  • TABLE 236 France Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
  • TABLE 237 France Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
  • TABLE 238 France Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
  • TABLE 239 France Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
  • TABLE 240 France Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
  • TABLE 241 Russia Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
  • TABLE 242 Russia Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
  • TABLE 243 Russia Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
  • TABLE 244 Russia Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
  • TABLE 245 Russia Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
  • TABLE 246 Russia Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
  • TABLE 247 Russia Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
  • TABLE 248 Russia Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
  • TABLE 249 Russia Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
  • TABLE 250 Russia Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
  • TABLE 251 Russia Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
  • TABLE 252 Russia Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
  • TABLE 253 Spain Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
  • TABLE 254 Spain Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
  • TABLE 255 Spain Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
  • TABLE 256 Spain Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
  • TABLE 257 Spain Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
  • TABLE 258 Spain Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
  • TABLE 259 Spain Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
  • TABLE 260 Spain Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
  • TABLE 261 Spain Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
  • TABLE 262 Spain Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
  • TABLE 263 Spain Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
  • TABLE 264 Spain Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
  • TABLE 265 Italy Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
  • TABLE 266 Italy Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
  • TABLE 267 Italy Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
  • TABLE 268 Italy Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
  • TABLE 269 Italy Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
  • TABLE 270 Italy Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
  • TABLE 271 Italy Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
  • TABLE 272 Italy Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
  • TABLE 273 Italy Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
  • TABLE 274 Italy Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
  • TABLE 275 Italy Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
  • TABLE 276 Italy Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
  • TABLE 277 Rest of Europe Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
  • TABLE 278 Rest of Europe Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
  • TABLE 279 Rest of Europe Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
  • TABLE 280 Rest of Europe Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
  • TABLE 281 Rest of Europe Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
  • TABLE 282 Rest of Europe Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
  • TABLE 283 Rest of Europe Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
  • TABLE 284 Rest of Europe Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
  • TABLE 285 Rest of Europe Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
  • TABLE 286 Rest of Europe Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
  • TABLE 287 Rest of Europe Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
  • TABLE 288 Rest of Europe Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
  • TABLE 289 Asia Pacific Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
  • TABLE 290 Asia Pacific Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
  • TABLE 291 Asia Pacific Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
  • TABLE 292 Asia Pacific Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
  • TABLE 293 Asia Pacific Reagents & Consumables Market by Country, 2019 - 2022, USD Million
  • TABLE 294 Asia Pacific Reagents & Consumables Market by Country, 2023 - 2030, USD Million
  • TABLE 295 Asia Pacific Analyzers Market by Country, 2019 - 2022, USD Million
  • TABLE 296 Asia Pacific Analyzers Market by Country, 2023 - 2030, USD Million
  • TABLE 297 Asia Pacific Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
  • TABLE 298 Asia Pacific Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
  • TABLE 299 Asia Pacific Deep Vein Thrombosis (DVT) Market by Country, 2019 - 2022, USD Million
  • TABLE 300 Asia Pacific Deep Vein Thrombosis (DVT) Market by Country, 2023 - 2030, USD Million
  • TABLE 301 Asia Pacific Pulmonary Embolism (PE) Market by Country, 2019 - 2022, USD Million
  • TABLE 302 Asia Pacific Pulmonary Embolism (PE) Market by Country, 2023 - 2030, USD Million
  • TABLE 303 Asia Pacific Disseminated Intravascular Coagulation (DIC) & Others Market by Country, 2019 - 2022, USD Million
  • TABLE 304 Asia Pacific Disseminated Intravascular Coagulation (DIC) & Others Market by Country, 2023 - 2030, USD Million
  • TABLE 305 Asia Pacific Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
  • TABLE 306 Asia Pacific Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
  • TABLE 307 Asia Pacific Diagnostic Centers Market by Country, 2019 - 2022, USD Million
  • TABLE 308 Asia Pacific Diagnostic Centers Market by Country, 2023 - 2030, USD Million
  • TABLE 309 Asia Pacific Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
  • TABLE 310 Asia Pacific Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
  • TABLE 311 Asia Pacific Academic & Research Institutes and Others Market by Country, 2019 - 2022, USD Million
  • TABLE 312 Asia Pacific Academic & Research Institutes and Others Market by Country, 2023 - 2030, USD Million
  • TABLE 313 Asia Pacific Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
  • TABLE 314 Asia Pacific Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
  • TABLE 315 Asia Pacific Clinical Laboratory Tests Market by Country, 2019 - 2022, USD Million
  • TABLE 316 Asia Pacific Clinical Laboratory Tests Market by Country, 2023 - 2030, USD Million
  • TABLE 317 Asia Pacific Point-of-Care Tests Market by Country, 2019 - 2022, USD Million
  • TABLE 318 Asia Pacific Point-of-Care Tests Market by Country, 2023 - 2030, USD Million
  • TABLE 319 Asia Pacific Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
  • TABLE 320 Asia Pacific Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
  • TABLE 321 Asia Pacific Post-Thrombin (PT) Market by Country, 2019 - 2022, USD Million
  • TABLE 322 Asia Pacific Post-Thrombin (PT) Market by Country, 2023 - 2030, USD Million
  • TABLE 323 Asia Pacific Activated Partial Thromboplastin Time (APTT) Test Market by Country, 2019 - 2022, USD Million
  • TABLE 324 Asia Pacific Activated Partial Thromboplastin Time (APTT) Test Market by Country, 2023 - 2030, USD Million
  • TABLE 325 Asia Pacific D-Dimer Market by Country, 2019 - 2022, USD Million
  • TABLE 326 Asia Pacific D-Dimer Market by Country, 2023 - 2030, USD Million
  • TABLE 327 Asia Pacific Anti-Thrombin III Market by Country, 2019 - 2022, USD Million
  • TABLE 328 Asia Pacific Anti-Thrombin III Market by Country, 2023 - 2030, USD Million
  • TABLE 329 Asia Pacific Plasminogen & Fibrinogen Market by Country, 2019 - 2022, USD Million
  • TABLE 330 Asia Pacific Plasminogen & Fibrinogen Market by Country, 2023 - 2030, USD Million
  • TABLE 331 Asia Pacific Soluble Fibrin Market by Country, 2019 - 2022, USD Million
  • TABLE 332 Asia Pacific Soluble Fibrin Market by Country, 2023 - 2030, USD Million
  • TABLE 333 Asia Pacific Selectins Market by Country, 2019 - 2022, USD Million
  • TABLE 334 Asia Pacific Selectins Market by Country, 2023 - 2030, USD Million
  • TABLE 335 Asia Pacific Factor VIII Market by Country, 2019 - 2022, USD Million
  • TABLE 336 Asia Pacific Factor VIII Market by Country, 2023 - 2030, USD Million
  • TABLE 337 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
  • TABLE 338 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
  • TABLE 339 Asia Pacific Thrombosis And Hemostasis Biomarkers Market by Country, 2019 - 2022, USD Million
  • TABLE 340 Asia Pacific Thrombosis And Hemostasis Biomarkers Market by Country, 2023 - 2030, USD Million
  • TABLE 341 China Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
  • TABLE 342 China Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
  • TABLE 343 China Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
  • TABLE 344 China Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
  • TABLE 345 China Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
  • TABLE 346 China Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
  • TABLE 347 China Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
  • TABLE 348 China Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
  • TABLE 349 China Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
  • TABLE 350 China Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
  • TABLE 351 China Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
  • TABLE 352 China Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
  • TABLE 353 Japan Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
  • TABLE 354 Japan Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
  • TABLE 355 Japan Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
  • TABLE 356 Japan Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
  • TABLE 357 Japan Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
  • TABLE 358 Japan Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
  • TABLE 359 Japan Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
  • TABLE 360 Japan Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
  • TABLE 361 Japan Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
  • TABLE 362 Japan Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
  • TABLE 363 Japan Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
  • TABLE 364 Japan Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
  • TABLE 365 India Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
  • TABLE 366 India Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
  • TABLE 367 India Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
  • TABLE 368 India Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
  • TABLE 369 India Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
  • TABLE 370 India Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
  • TABLE 371 India Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
  • TABLE 372 India Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
  • TABLE 373 India Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
  • TABLE 374 India Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
  • TABLE 375 India Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
  • TABLE 376 India Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
  • TABLE 377 South Korea Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
  • TABLE 378 South Korea Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
  • TABLE 379 South Korea Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
  • TABLE 380 South Korea Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
  • TABLE 381 South Korea Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
  • TABLE 382 South Korea Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
  • TABLE 383 South Korea Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
  • TABLE 384 South Korea Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
  • TABLE 385 South Korea Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
  • TABLE 386 South Korea Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
  • TABLE 387 South Korea Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
  • TABLE 388 South Korea Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
  • TABLE 389 Singapore Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
  • TABLE 390 Singapore Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
  • TABLE 391 Singapore Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
  • TABLE 392 Singapore Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
  • TABLE 393 Singapore Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
  • TABLE 394 Singapore Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
  • TABLE 395 Singapore Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
  • TABLE 396 Singapore Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
  • TABLE 397 Singapore Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
  • TABLE 398 Singapore Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
  • TABLE 399 Singapore Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
  • TABLE 400 Singapore Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
  • TABLE 401 Malaysia Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
  • TABLE 402 Malaysia Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
  • TABLE 403 Malaysia Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
  • TABLE 404 Malaysia Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
  • TABLE 405 Malaysia Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
  • TABLE 406 Malaysia Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
  • TABLE 407 Malaysia Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
  • TABLE 408 Malaysia Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
  • TABLE 409 Malaysia Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
  • TABLE 410 Malaysia Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
  • TABLE 411 Malaysia Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
  • TABLE 412 Malaysia Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
  • TABLE 413 Rest of Asia Pacific Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
  • TABLE 414 Rest of Asia Pacific Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
  • TABLE 415 Rest of Asia Pacific Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
  • TABLE 416 Rest of Asia Pacific Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
  • TABLE 417 Rest of Asia Pacific Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
  • TABLE 418 Rest of Asia Pacific Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
  • TABLE 419 Rest of Asia Pacific Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
  • TABLE 420 Rest of Asia Pacific Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
  • TABLE 421 Rest of Asia Pacific Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
  • TABLE 422 Rest of Asia Pacific Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
  • TABLE 423 Rest of Asia Pacific Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
  • TABLE 424 Rest of Asia Pacific Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
  • TABLE 425 LAMEA Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
  • TABLE 426 LAMEA Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
  • TABLE 427 LAMEA Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
  • TABLE 428 LAMEA Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
  • TABLE 429 LAMEA Reagents & Consumables Market by Country, 2019 - 2022, USD Million
  • TABLE 430 LAMEA Reagents & Consumables Market by Country, 2023 - 2030, USD Million
  • TABLE 431 LAMEA Analyzers Market by Country, 2019 - 2022, USD Million
  • TABLE 432 LAMEA Analyzers Market by Country, 2023 - 2030, USD Million
  • TABLE 433 LAMEA Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
  • TABLE 434 LAMEA Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
  • TABLE 435 LAMEA Deep Vein Thrombosis (DVT) Market by Country, 2019 - 2022, USD Million
  • TABLE 436 LAMEA Deep Vein Thrombosis (DVT) Market by Country, 2023 - 2030, USD Million
  • TABLE 437 LAMEA Pulmonary Embolism (PE) Market by Country, 2019 - 2022, USD Million
  • TABLE 438 LAMEA Pulmonary Embolism (PE) Market by Country, 2023 - 2030, USD Million
  • TABLE 439 LAMEA Disseminated Intravascular Coagulation (DIC) & Others Market by Country, 2019 - 2022, USD Million
  • TABLE 440 LAMEA Disseminated Intravascular Coagulation (DIC) & Others Market by Country, 2023 - 2030, USD Million
  • TABLE 441 LAMEA Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
  • TABLE 442 LAMEA Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
  • TABLE 443 LAMEA Diagnostic Centers Market by Country, 2019 - 2022, USD Million
  • TABLE 444 LAMEA Diagnostic Centers Market by Country, 2023 - 2030, USD Million
  • TABLE 445 LAMEA Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
  • TABLE 446 LAMEA Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
  • TABLE 447 LAMEA Academic & Research Institutes and Others Market by Country, 2019 - 2022, USD Million
  • TABLE 448 LAMEA Academic & Research Institutes and Others Market by Country, 2023 - 2030, USD Million
  • TABLE 449 LAMEA Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
  • TABLE 450 LAMEA Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
  • TABLE 451 LAMEA Clinical Laboratory Tests Market by Country, 2019 - 2022, USD Million
  • TABLE 452 LAMEA Clinical Laboratory Tests Market by Country, 2023 - 2030, USD Million
  • TABLE 453 LAMEA Point-of-Care Tests Market by Country, 2019 - 2022, USD Million
  • TABLE 454 LAMEA Point-of-Care Tests Market by Country, 2023 - 2030, USD Million
  • TABLE 455 LAMEA Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
  • TABLE 456 LAMEA Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
  • TABLE 457 LAMEA Post-Thrombin (PT) Market by Country, 2019 - 2022, USD Million
  • TABLE 458 LAMEA Post-Thrombin (PT) Market by Country, 2023 - 2030, USD Million
  • TABLE 459 LAMEA Activated Partial Thromboplastin Time (APTT) Test Market by Country, 2019 - 2022, USD Million
  • TABLE 460 LAMEA Activated Partial Thromboplastin Time (APTT) Test Market by Country, 2023 - 2030, USD Million
  • TABLE 461 LAMEA D-Dimer Market by Country, 2019 - 2022, USD Million
  • TABLE 462 LAMEA D-Dimer Market by Country, 2023 - 2030, USD Million
  • TABLE 463 LAMEA Anti-Thrombin III Market by Country, 2019 - 2022, USD Million
  • TABLE 464 LAMEA Anti-Thrombin III Market by Country, 2023 - 2030, USD Million
  • TABLE 465 LAMEA Plasminogen & Fibrinogen Market by Country, 2019 - 2022, USD Million
  • TABLE 466 LAMEA Plasminogen & Fibrinogen Market by Country, 2023 - 2030, USD Million
  • TABLE 467 LAMEA Soluble Fibrin Market by Country, 2019 - 2022, USD Million
  • TABLE 468 LAMEA Soluble Fibrin Market by Country, 2023 - 2030, USD Million
  • TABLE 469 LAMEA Selectins Market by Country, 2019 - 2022, USD Million
  • TABLE 470 LAMEA Selectins Market by Country, 2023 - 2030, USD Million
  • TABLE 471 LAMEA Factor VIII Market by Country, 2019 - 2022, USD Million
  • TABLE 472 LAMEA Factor VIII Market by Country, 2023 - 2030, USD Million
  • TABLE 473 LAMEA Others Market by Country, 2019 - 2022, USD Million
  • TABLE 474 LAMEA Others Market by Country, 2023 - 2030, USD Million
  • TABLE 475 LAMEA Thrombosis And Hemostasis Biomarkers Market by Country, 2019 - 2022, USD Million
  • TABLE 476 LAMEA Thrombosis And Hemostasis Biomarkers Market by Country, 2023 - 2030, USD Million
  • TABLE 477 Brazil Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
  • TABLE 478 Brazil Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
  • TABLE 479 Brazil Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
  • TABLE 480 Brazil Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
  • TABLE 481 Brazil Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
  • TABLE 482 Brazil Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
  • TABLE 483 Brazil Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
  • TABLE 484 Brazil Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
  • TABLE 485 Brazil Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
  • TABLE 486 Brazil Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
  • TABLE 487 Brazil Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
  • TABLE 488 Brazil Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
  • TABLE 489 Argentina Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
  • TABLE 490 Argentina Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
  • TABLE 491 Argentina Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
  • TABLE 492 Argentina Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
  • TABLE 493 Argentina Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
  • TABLE 494 Argentina Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
  • TABLE 495 Argentina Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
  • TABLE 496 Argentina Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
  • TABLE 497 Argentina Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
  • TABLE 498 Argentina Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
  • TABLE 499 Argentina Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
  • TABLE 500 Argentina Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
  • TABLE 501 UAE Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
  • TABLE 502 UAE Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
  • TABLE 503 UAE Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
  • TABLE 504 UAE Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
  • TABLE 505 UAE Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
  • TABLE 506 UAE Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
  • TABLE 507 UAE Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
  • TABLE 508 UAE Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
  • TABLE 509 UAE Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
  • TABLE 510 UAE Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
  • TABLE 511 UAE Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
  • TABLE 512 UAE Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
  • TABLE 513 Saudi Arabia Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
  • TABLE 514 Saudi Arabia Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
  • TABLE 515 Saudi Arabia Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
  • TABLE 516 Saudi Arabia Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
  • TABLE 517 Saudi Arabia Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
  • TABLE 518 Saudi Arabia Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
  • TABLE 519 Saudi Arabia Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
  • TABLE 520 Saudi Arabia Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
  • TABLE 521 Saudi Arabia Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
  • TABLE 522 Saudi Arabia Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
  • TABLE 523 Saudi Arabia Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
  • TABLE 524 Saudi Arabia Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
  • TABLE 525 South Africa Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
  • TABLE 526 South Africa Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
  • TABLE 527 South Africa Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
  • TABLE 528 South Africa Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
  • TABLE 529 South Africa Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
  • TABLE 530 South Africa Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
  • TABLE 531 South Africa Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
  • TABLE 532 South Africa Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
  • TABLE 533 South Africa Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
  • TABLE 534 South Africa Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
  • TABLE 535 South Africa Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
  • TABLE 536 South Africa Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
  • TABLE 537 Nigeria Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
  • TABLE 538 Nigeria Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
  • TABLE 539 Nigeria Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
  • TABLE 540 Nigeria Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
  • TABLE 541 Nigeria Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
  • TABLE 542 Nigeria Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
  • TABLE 543 Nigeria Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
  • TABLE 544 Nigeria Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
  • TABLE 545 Nigeria Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
  • TABLE 546 Nigeria Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
  • TABLE 547 Nigeria Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
  • TABLE 548 Nigeria Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
  • TABLE 549 Rest of LAMEA Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
  • TABLE 550 Rest of LAMEA Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
  • TABLE 551 Rest of LAMEA Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
  • TABLE 552 Rest of LAMEA Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
  • TABLE 553 Rest of LAMEA Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
  • TABLE 554 Rest of LAMEA Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
  • TABLE 555 Rest of LAMEA Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
  • TABLE 556 Rest of LAMEA Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
  • TABLE 557 Rest of LAMEA Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
  • TABLE 558 Rest of LAMEA Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
  • TABLE 559 Rest of LAMEA Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
  • TABLE 560 Rest of LAMEA Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
  • TABLE 561 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 562 KEY INFORMATION - F. Hoffmann-La Roche Ltd.
  • TABLE 563 Key Information - Siemens Healthineers AG
  • TABLE 564 Key Information - Abbott Laboratories
  • TABLE 565 Key information - BioMerieux S.A.
  • TABLE 566 key Information - Horiba Ltd.
  • TABLE 567 key information - QuidelOrtho Corporation
  • TABLE 568 Key Information - Werfen, S.A.
  • TABLE 569 Key Information - Diazyme Laboratories, Inc.
  • TABLE 570 Key Information - BioMedica Diagnostics Inc.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Thrombosis And Hemostasis Biomarkers Market share by Product, 2022
  • FIG 3 Global Thrombosis And Hemostasis Biomarkers Market share by Product, 2030
  • FIG 4 Global Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2030, USD Million
  • FIG 5 Global Thrombosis And Hemostasis Biomarkers Market share by Application, 2022
  • FIG 6 Global Thrombosis And Hemostasis Biomarkers Market share by Application, 2030
  • FIG 7 Global Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2030, USD Million
  • FIG 8 Global Thrombosis And Hemostasis Biomarkers Market share by End-use, 2022
  • FIG 9 Global Thrombosis And Hemostasis Biomarkers Market share by End-use, 2030
  • FIG 10 Global Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2030, USD Million
  • FIG 11 Global Thrombosis And Hemostasis Biomarkers Market share by Location, 2022
  • FIG 12 Global Thrombosis And Hemostasis Biomarkers Market share by Location, 2030
  • FIG 13 Global Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2030, USD Million
  • FIG 14 Global Thrombosis And Hemostasis Biomarkers Market share by Type, 2022
  • FIG 15 Global Thrombosis And Hemostasis Biomarkers Market share by Type, 2030
  • FIG 16 Global Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2030, USD Million
  • FIG 17 Global Thrombosis And Hemostasis Biomarkers Market share by Region, 2022
  • FIG 18 Global Thrombosis And Hemostasis Biomarkers Market share by Region, 2030
  • FIG 19 Global Thrombosis And Hemostasis Biomarkers Market by Region, 2019 - 2030, USD Million
  • FIG 20 Swot analysis: thermo fisher scientific, inc.
  • FIG 21 Swot analysis: Siemens AG
  • FIG 22 Swot analysis: Abbott laboratories
目次

The Global Thrombosis And Hemostasis Biomarkers Market size is expected to reach $7.4 billion by 2030, rising at a market growth of 5.6% CAGR during the forecast period.

Clinical Laboratory Test are growing for evaluating the extremity of the illness and inform therapy choices. Moreover, the growing aging population emerges the need for frequent lab tests especially in emerging nations. Therefore, clinical laboratory tests are expected to capture more than 65% share of the market by 2029. For example, by 2050, it is expected that the world population will reach almost 1.5 billion, up by more than triple. Additionally, it is anticipated that the proportion of senior individuals worldwide will rise to 16.0% in this period. By the middle of the 21st century, one in six individuals will be 65 or older. The "population aging phenomenon" refers to the increasing prevalence and proportion of older people in the world's population. In addition, 703 million individuals worldwide in 2019 were 65 or older. Some of the factors impacting the market are increased occurrence of chronic disorders, rising demand for personalized medications, and limitations regarding the use of hemostasis biomarkers.

Chronic diseases or noncommunicable diseases (NCDs) are becoming more commonplace on an international level. Hemostasis and thrombosis tests help to regulate the occurrence of a variety of health conditions, illnesses, injuries, or afflictions of chronic diseases. Apart from helping patients recover quickly and achieve the greatest results, it supports further medical interventions, like surgical procedures. The rapidly rising need for personalized medicine to treat various illnesses and disorders in accordance with a specific patient's needs is one of the key drivers fueling the demand. This element is promoting the market. The COVID-19 pandemic favorably impacted the market. According to the National Library of Medicine findings in September 2020, thrombotic problems were quite common in COVID-19 patients. These complications were a contributing factor in the high death and morbidity rates. The pandemic raised awareness, generating major new opportunities for market competition.

However, on the question of hemostasis and how to manage cases with significant damage, discussions among doctors and other medical professionals are still ongoing. A hemostatic agent by itself would not be very helpful in the event that a person suffers a significant injury that causes excessive blood loss. Hence, in the coming years, these factors may impede the growth of the market.

Product Outlook

Based on product, the market is characterized into analyzers and reagents & consumables. The reagents and consumables segment garnered the highest revenue share in the market in 2022. The substantial need for diagnostic tools, the rising prevalence of coagulation and bleeding disorders, and recent product introductions are all factors that contributed to the segment's market dominance. Throughout the projected period, the reagents and consumables segment are anticipated to increase significantly.

Location Outlook

On the basis of location, the market is classified into clinical laboratory tests and point-of-care tests. The point-of-care tests segment recorded a significant revenue share in the market in 2022. Since POC tests can deliver answers in just a few minutes, they are convenient for healthcare practitioners. The market is driven by POCT, which enables diagnostic tests to be conducted outside of traditional clinical laboratory environments, such as doctor's offices, ERs, or even patients' homes.

Type Outlook

By type, the market is divided into D-dimer, anti-thrombin III, plasminogen & fibrinogen, soluble fibrin, selectins, factor VIII, PT, APTT, and others. The post-thrombin (PT) segment witnessed the maximum revenue share in the market in 2022. The test makes it possible to keep track of how well anticoagulant drugs, such as warfarin, which are intended to stop blood clots, are working. Additionally, it is used to diagnose liver illnesses and blood disorders. For people who are not using blood thinners, it normally takes blood plasma 11 to 13.5 seconds to clot.

Application Outlook

Based on application, the market is segmented into deep vein thrombosis (DVT), pulmonary embolism (PE), disseminated intravascular coagulation (DIC), and others. The pulmonary embolism (PE) segment witnessed a significant revenue share in the market in 2022. Blood clots in the lungs' blood vessels can also form in other body regions like the arms or legs and lead to the condition known as pulmonary embolism. PE is one of the most prevalent forms of cardiovascular disease, ranking third after heart attack and stroke. For instance, the American Lung Association estimates that almost 900,00 Americans are affected with PE each year as of January 2023.

End Use Outlook

On the basis of end-use, the market is categorized into hospitals & clinics, academic & research institutes, diagnostic centers, and others. The diagnostic centers segment garnered the largest revenue share in the market in 2022. The increase in hospitals' reliance on diagnostic centers for testing and assessment is likely to be responsible for the share, which further fuels the segment's rapid expansion. The expansion of government initiatives to offer various amenities, such as reimbursement for diagnostic testing, is another significant element anticipated to fuel industry growth.

Regional Outlook

Region wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment acquired the maximum revenue share in the market in 2022. The rising frequency of thrombosis and hemostasis disorders, technological developments, and ongoing R&D in thrombosis and hemostasis biomarkers are the main factors propelling the market in this region. As an illustration, according to the Centers for Disease Control and Prevention, the predicted yearly mortality of venous thromboembolism (VTE) in this the US ranges from 60,000 to 100,000.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Siemens Healthineers AG (Siemens AG), Abbott Laboratories, BioMerieux S.A., Horiba Ltd., QuidelOrtho Corporation, Werfen, S.A., Diazyme Laboratories, Inc. (General Atomics) and BioMedica Diagnostics Inc. (Scotia Investments Family of Companies).

Scope of the Study

Market Segments covered in the Report:

By Product

  • Reagents & Consumables
  • Analyzers

By Application

  • Deep Vein Thrombosis (DVT)
  • Pulmonary Embolism (PE)
  • Disseminated Intravascular Coagulation (DIC) & Others

By End-Use

  • Diagnostic Centers
  • Hospitals & Clinics
  • Academic & Research Institutes and Others

By Location

  • Clinical Laboratory Tests
  • Point-of-Care Tests

By Type

  • Post-Thrombin (PT)
  • Activated Partial Thromboplastin Time (APTT) Test
  • D-Dimer
  • Anti-Thrombin III
  • Plasminogen & Fibrinogen
  • Soluble Fibrin
  • Selectins
  • Factor VIII
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthineers AG (Siemens AG)
  • Abbott Laboratories
  • BioMerieux S.A.
  • Horiba Ltd.
  • QuidelOrtho Corporation
  • Werfen, S.A.
  • Diazyme Laboratories, Inc. (General Atomics)
  • BioMedica Diagnostics Inc. (Scotia Investments Family of Companies)

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Thrombosis And Hemostasis Biomarkers Market, by Product
    • 1.4.2 Global Thrombosis And Hemostasis Biomarkers Market, by Application
    • 1.4.3 Global Thrombosis And Hemostasis Biomarkers Market, by End-Use
    • 1.4.4 Global Thrombosis And Hemostasis Biomarkers Market, by Location
    • 1.4.5 Global Thrombosis And Hemostasis Biomarkers Market, by Type
    • 1.4.6 Global Thrombosis And Hemostasis Biomarkers Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Thrombosis And Hemostasis Biomarkers Market by Product

  • 3.1 Global Reagents & Consumables Market by Region
  • 3.2 Global Analyzers Market by Region

Chapter 4. Global Thrombosis And Hemostasis Biomarkers Market by Application

  • 4.1 Global Deep Vein Thrombosis (DVT) Market by Region
  • 4.2 Global Pulmonary Embolism (PE) Market by Region
  • 4.3 Global Disseminated Intravascular Coagulation (DIC) & Others Market by Region

Chapter 5. Global Thrombosis And Hemostasis Biomarkers Market by End-use

  • 5.1 Global Diagnostic Centers Market by Region
  • 5.2 Global Hospitals & Clinics Market by Region
  • 5.3 Global Academic & Research Institutes and Others Market by Region

Chapter 6. Global Thrombosis And Hemostasis Biomarkers Market by Location

  • 6.1 Global Clinical Laboratory Tests Market by Region
  • 6.2 Global Point-of-Care Tests Market by Region

Chapter 7. Global Thrombosis And Hemostasis Biomarkers Market by Type

  • 7.1 Global Post-Thrombin (PT) Market by Region
  • 7.2 Global Activated Partial Thromboplastin Time (APTT) Test Market by Region
  • 7.3 Global D-Dimer Market by Region
  • 7.4 Global Anti-Thrombin III Market by Region
  • 7.5 Global Plasminogen & Fibrinogen Market by Region
  • 7.6 Global Soluble Fibrin Market by Region
  • 7.7 Global Selectins Market by Region
  • 7.8 Global Factor VIII Market by Region
  • 7.9 Global Others Market by Region

Chapter 8. Global Thrombosis And Hemostasis Biomarkers Market by Region

  • 8.1 North America Thrombosis And Hemostasis Biomarkers Market
    • 8.1.1 North America Thrombosis And Hemostasis Biomarkers Market by Product
      • 8.1.1.1 North America Reagents & Consumables Market by Country
      • 8.1.1.2 North America Analyzers Market by Country
    • 8.1.2 North America Thrombosis And Hemostasis Biomarkers Market by Application
      • 8.1.2.1 North America Deep Vein Thrombosis (DVT) Market by Country
      • 8.1.2.2 North America Pulmonary Embolism (PE) Market by Country
      • 8.1.2.3 North America Disseminated Intravascular Coagulation (DIC) & Others Market by Country
    • 8.1.3 North America Thrombosis And Hemostasis Biomarkers Market by End-use
      • 8.1.3.1 North America Diagnostic Centers Market by Country
      • 8.1.3.2 North America Hospitals & Clinics Market by Country
      • 8.1.3.3 North America Academic & Research Institutes and Others Market by Country
    • 8.1.4 North America Thrombosis And Hemostasis Biomarkers Market by Location
      • 8.1.4.1 North America Clinical Laboratory Tests Market by Country
      • 8.1.4.2 North America Point-of-Care Tests Market by Country
    • 8.1.5 North America Thrombosis And Hemostasis Biomarkers Market by Type
      • 8.1.5.1 North America Post-Thrombin (PT) Market by Country
      • 8.1.5.2 North America Activated Partial Thromboplastin Time (APTT) Test Market by Country
      • 8.1.5.3 North America D-Dimer Market by Country
      • 8.1.5.4 North America Anti-Thrombin III Market by Country
      • 8.1.5.5 North America Plasminogen & Fibrinogen Market by Country
      • 8.1.5.6 North America Soluble Fibrin Market by Country
      • 8.1.5.7 North America Selectins Market by Country
      • 8.1.5.8 North America Factor VIII Market by Country
      • 8.1.5.9 North America Others Market by Country
    • 8.1.6 North America Thrombosis And Hemostasis Biomarkers Market by Country
      • 8.1.6.1 US Thrombosis And Hemostasis Biomarkers Market
        • 8.1.6.1.1 US Thrombosis And Hemostasis Biomarkers Market by Product
        • 8.1.6.1.2 US Thrombosis And Hemostasis Biomarkers Market by Application
        • 8.1.6.1.3 US Thrombosis And Hemostasis Biomarkers Market by End-use
        • 8.1.6.1.4 US Thrombosis And Hemostasis Biomarkers Market by Location
        • 8.1.6.1.5 US Thrombosis And Hemostasis Biomarkers Market by Type
      • 8.1.6.2 Canada Thrombosis And Hemostasis Biomarkers Market
        • 8.1.6.2.1 Canada Thrombosis And Hemostasis Biomarkers Market by Product
        • 8.1.6.2.2 Canada Thrombosis And Hemostasis Biomarkers Market by Application
        • 8.1.6.2.3 Canada Thrombosis And Hemostasis Biomarkers Market by End-use
        • 8.1.6.2.4 Canada Thrombosis And Hemostasis Biomarkers Market by Location
        • 8.1.6.2.5 Canada Thrombosis And Hemostasis Biomarkers Market by Type
      • 8.1.6.3 Mexico Thrombosis And Hemostasis Biomarkers Market
        • 8.1.6.3.1 Mexico Thrombosis And Hemostasis Biomarkers Market by Product
        • 8.1.6.3.2 Mexico Thrombosis And Hemostasis Biomarkers Market by Application
        • 8.1.6.3.3 Mexico Thrombosis And Hemostasis Biomarkers Market by End-use
        • 8.1.6.3.4 Mexico Thrombosis And Hemostasis Biomarkers Market by Location
        • 8.1.6.3.5 Mexico Thrombosis And Hemostasis Biomarkers Market by Type
      • 8.1.6.4 Rest of North America Thrombosis And Hemostasis Biomarkers Market
        • 8.1.6.4.1 Rest of North America Thrombosis And Hemostasis Biomarkers Market by Product
        • 8.1.6.4.2 Rest of North America Thrombosis And Hemostasis Biomarkers Market by Application
        • 8.1.6.4.3 Rest of North America Thrombosis And Hemostasis Biomarkers Market by End-use
        • 8.1.6.4.4 Rest of North America Thrombosis And Hemostasis Biomarkers Market by Location
        • 8.1.6.4.5 Rest of North America Thrombosis And Hemostasis Biomarkers Market by Type
  • 8.2 Europe Thrombosis And Hemostasis Biomarkers Market
    • 8.2.1 Europe Thrombosis And Hemostasis Biomarkers Market by Product
      • 8.2.1.1 Europe Reagents & Consumables Market by Country
      • 8.2.1.2 Europe Analyzers Market by Country
    • 8.2.2 Europe Thrombosis And Hemostasis Biomarkers Market by Application
      • 8.2.2.1 Europe Deep Vein Thrombosis (DVT) Market by Country
      • 8.2.2.2 Europe Pulmonary Embolism (PE) Market by Country
      • 8.2.2.3 Europe Disseminated Intravascular Coagulation (DIC) & Others Market by Country
    • 8.2.3 Europe Thrombosis And Hemostasis Biomarkers Market by End-use
      • 8.2.3.1 Europe Diagnostic Centers Market by Country
      • 8.2.3.2 Europe Hospitals & Clinics Market by Country
      • 8.2.3.3 Europe Academic & Research Institutes and Others Market by Country
    • 8.2.4 Europe Thrombosis And Hemostasis Biomarkers Market by Location
      • 8.2.4.1 Europe Clinical Laboratory Tests Market by Country
      • 8.2.4.2 Europe Point-of-Care Tests Market by Country
    • 8.2.5 Europe Thrombosis And Hemostasis Biomarkers Market by Type
      • 8.2.5.1 Europe Post-Thrombin (PT) Market by Country
      • 8.2.5.2 Europe Activated Partial Thromboplastin Time (APTT) Test Market by Country
      • 8.2.5.3 Europe D-Dimer Market by Country
      • 8.2.5.4 Europe Anti-Thrombin III Market by Country
      • 8.2.5.5 Europe Plasminogen & Fibrinogen Market by Country
      • 8.2.5.6 Europe Soluble Fibrin Market by Country
      • 8.2.5.7 Europe Selectins Market by Country
      • 8.2.5.8 Europe Factor VIII Market by Country
      • 8.2.5.9 Europe Others Market by Country
    • 8.2.6 Europe Thrombosis And Hemostasis Biomarkers Market by Country
      • 8.2.6.1 Germany Thrombosis And Hemostasis Biomarkers Market
        • 8.2.6.1.1 Germany Thrombosis And Hemostasis Biomarkers Market by Product
        • 8.2.6.1.2 Germany Thrombosis And Hemostasis Biomarkers Market by Application
        • 8.2.6.1.3 Germany Thrombosis And Hemostasis Biomarkers Market by End-use
        • 8.2.6.1.4 Germany Thrombosis And Hemostasis Biomarkers Market by Location
        • 8.2.6.1.5 Germany Thrombosis And Hemostasis Biomarkers Market by Type
      • 8.2.6.2 UK Thrombosis And Hemostasis Biomarkers Market
        • 8.2.6.2.1 UK Thrombosis And Hemostasis Biomarkers Market by Product
        • 8.2.6.2.2 UK Thrombosis And Hemostasis Biomarkers Market by Application
        • 8.2.6.2.3 UK Thrombosis And Hemostasis Biomarkers Market by End-use
        • 8.2.6.2.4 UK Thrombosis And Hemostasis Biomarkers Market by Location
        • 8.2.6.2.5 UK Thrombosis And Hemostasis Biomarkers Market by Type
      • 8.2.6.3 France Thrombosis And Hemostasis Biomarkers Market
        • 8.2.6.3.1 France Thrombosis And Hemostasis Biomarkers Market by Product
        • 8.2.6.3.2 France Thrombosis And Hemostasis Biomarkers Market by Application
        • 8.2.6.3.3 France Thrombosis And Hemostasis Biomarkers Market by End-use
        • 8.2.6.3.4 France Thrombosis And Hemostasis Biomarkers Market by Location
        • 8.2.6.3.5 France Thrombosis And Hemostasis Biomarkers Market by Type
      • 8.2.6.4 Russia Thrombosis And Hemostasis Biomarkers Market
        • 8.2.6.4.1 Russia Thrombosis And Hemostasis Biomarkers Market by Product
        • 8.2.6.4.2 Russia Thrombosis And Hemostasis Biomarkers Market by Application
        • 8.2.6.4.3 Russia Thrombosis And Hemostasis Biomarkers Market by End-use
        • 8.2.6.4.4 Russia Thrombosis And Hemostasis Biomarkers Market by Location
        • 8.2.6.4.5 Russia Thrombosis And Hemostasis Biomarkers Market by Type
      • 8.2.6.5 Spain Thrombosis And Hemostasis Biomarkers Market
        • 8.2.6.5.1 Spain Thrombosis And Hemostasis Biomarkers Market by Product
        • 8.2.6.5.2 Spain Thrombosis And Hemostasis Biomarkers Market by Application
        • 8.2.6.5.3 Spain Thrombosis And Hemostasis Biomarkers Market by End-use
        • 8.2.6.5.4 Spain Thrombosis And Hemostasis Biomarkers Market by Location
        • 8.2.6.5.5 Spain Thrombosis And Hemostasis Biomarkers Market by Type
      • 8.2.6.6 Italy Thrombosis And Hemostasis Biomarkers Market
        • 8.2.6.6.1 Italy Thrombosis And Hemostasis Biomarkers Market by Product
        • 8.2.6.6.2 Italy Thrombosis And Hemostasis Biomarkers Market by Application
        • 8.2.6.6.3 Italy Thrombosis And Hemostasis Biomarkers Market by End-use
        • 8.2.6.6.4 Italy Thrombosis And Hemostasis Biomarkers Market by Location
        • 8.2.6.6.5 Italy Thrombosis And Hemostasis Biomarkers Market by Type
      • 8.2.6.7 Rest of Europe Thrombosis And Hemostasis Biomarkers Market
        • 8.2.6.7.1 Rest of Europe Thrombosis And Hemostasis Biomarkers Market by Product
        • 8.2.6.7.2 Rest of Europe Thrombosis And Hemostasis Biomarkers Market by Application
        • 8.2.6.7.3 Rest of Europe Thrombosis And Hemostasis Biomarkers Market by End-use
        • 8.2.6.7.4 Rest of Europe Thrombosis And Hemostasis Biomarkers Market by Location
        • 8.2.6.7.5 Rest of Europe Thrombosis And Hemostasis Biomarkers Market by Type
  • 8.3 Asia Pacific Thrombosis And Hemostasis Biomarkers Market
    • 8.3.1 Asia Pacific Thrombosis And Hemostasis Biomarkers Market by Product
      • 8.3.1.1 Asia Pacific Reagents & Consumables Market by Country
      • 8.3.1.2 Asia Pacific Analyzers Market by Country
    • 8.3.2 Asia Pacific Thrombosis And Hemostasis Biomarkers Market by Application
      • 8.3.2.1 Asia Pacific Deep Vein Thrombosis (DVT) Market by Country
      • 8.3.2.2 Asia Pacific Pulmonary Embolism (PE) Market by Country
      • 8.3.2.3 Asia Pacific Disseminated Intravascular Coagulation (DIC) & Others Market by Country
    • 8.3.3 Asia Pacific Thrombosis And Hemostasis Biomarkers Market by End-use
      • 8.3.3.1 Asia Pacific Diagnostic Centers Market by Country
      • 8.3.3.2 Asia Pacific Hospitals & Clinics Market by Country
      • 8.3.3.3 Asia Pacific Academic & Research Institutes and Others Market by Country
    • 8.3.4 Asia Pacific Thrombosis And Hemostasis Biomarkers Market by Location
      • 8.3.4.1 Asia Pacific Clinical Laboratory Tests Market by Country
      • 8.3.4.2 Asia Pacific Point-of-Care Tests Market by Country
    • 8.3.5 Asia Pacific Thrombosis And Hemostasis Biomarkers Market by Type
      • 8.3.5.1 Asia Pacific Post-Thrombin (PT) Market by Country
      • 8.3.5.2 Asia Pacific Activated Partial Thromboplastin Time (APTT) Test Market by Country
      • 8.3.5.3 Asia Pacific D-Dimer Market by Country
      • 8.3.5.4 Asia Pacific Anti-Thrombin III Market by Country
      • 8.3.5.5 Asia Pacific Plasminogen & Fibrinogen Market by Country
      • 8.3.5.6 Asia Pacific Soluble Fibrin Market by Country
      • 8.3.5.7 Asia Pacific Selectins Market by Country
      • 8.3.5.8 Asia Pacific Factor VIII Market by Country
      • 8.3.5.9 Asia Pacific Others Market by Country
    • 8.3.6 Asia Pacific Thrombosis And Hemostasis Biomarkers Market by Country
      • 8.3.6.1 China Thrombosis And Hemostasis Biomarkers Market
        • 8.3.6.1.1 China Thrombosis And Hemostasis Biomarkers Market by Product
        • 8.3.6.1.2 China Thrombosis And Hemostasis Biomarkers Market by Application
        • 8.3.6.1.3 China Thrombosis And Hemostasis Biomarkers Market by End-use
        • 8.3.6.1.4 China Thrombosis And Hemostasis Biomarkers Market by Location
        • 8.3.6.1.5 China Thrombosis And Hemostasis Biomarkers Market by Type
      • 8.3.6.2 Japan Thrombosis And Hemostasis Biomarkers Market
        • 8.3.6.2.1 Japan Thrombosis And Hemostasis Biomarkers Market by Product
        • 8.3.6.2.2 Japan Thrombosis And Hemostasis Biomarkers Market by Application
        • 8.3.6.2.3 Japan Thrombosis And Hemostasis Biomarkers Market by End-use
        • 8.3.6.2.4 Japan Thrombosis And Hemostasis Biomarkers Market by Location
        • 8.3.6.2.5 Japan Thrombosis And Hemostasis Biomarkers Market by Type
      • 8.3.6.3 India Thrombosis And Hemostasis Biomarkers Market
        • 8.3.6.3.1 India Thrombosis And Hemostasis Biomarkers Market by Product
        • 8.3.6.3.2 India Thrombosis And Hemostasis Biomarkers Market by Application
        • 8.3.6.3.3 India Thrombosis And Hemostasis Biomarkers Market by End-use
        • 8.3.6.3.4 India Thrombosis And Hemostasis Biomarkers Market by Location
        • 8.3.6.3.5 India Thrombosis And Hemostasis Biomarkers Market by Type
      • 8.3.6.4 South Korea Thrombosis And Hemostasis Biomarkers Market
        • 8.3.6.4.1 South Korea Thrombosis And Hemostasis Biomarkers Market by Product
        • 8.3.6.4.2 South Korea Thrombosis And Hemostasis Biomarkers Market by Application
        • 8.3.6.4.3 South Korea Thrombosis And Hemostasis Biomarkers Market by End-use
        • 8.3.6.4.4 South Korea Thrombosis And Hemostasis Biomarkers Market by Location
        • 8.3.6.4.5 South Korea Thrombosis And Hemostasis Biomarkers Market by Type
      • 8.3.6.5 Singapore Thrombosis And Hemostasis Biomarkers Market
        • 8.3.6.5.1 Singapore Thrombosis And Hemostasis Biomarkers Market by Product
        • 8.3.6.5.2 Singapore Thrombosis And Hemostasis Biomarkers Market by Application
        • 8.3.6.5.3 Singapore Thrombosis And Hemostasis Biomarkers Market by End-use
        • 8.3.6.5.4 Singapore Thrombosis And Hemostasis Biomarkers Market by Location
        • 8.3.6.5.5 Singapore Thrombosis And Hemostasis Biomarkers Market by Type
      • 8.3.6.6 Malaysia Thrombosis And Hemostasis Biomarkers Market
        • 8.3.6.6.1 Malaysia Thrombosis And Hemostasis Biomarkers Market by Product
        • 8.3.6.6.2 Malaysia Thrombosis And Hemostasis Biomarkers Market by Application
        • 8.3.6.6.3 Malaysia Thrombosis And Hemostasis Biomarkers Market by End-use
        • 8.3.6.6.4 Malaysia Thrombosis And Hemostasis Biomarkers Market by Location
        • 8.3.6.6.5 Malaysia Thrombosis And Hemostasis Biomarkers Market by Type
      • 8.3.6.7 Rest of Asia Pacific Thrombosis And Hemostasis Biomarkers Market
        • 8.3.6.7.1 Rest of Asia Pacific Thrombosis And Hemostasis Biomarkers Market by Product
        • 8.3.6.7.2 Rest of Asia Pacific Thrombosis And Hemostasis Biomarkers Market by Application
        • 8.3.6.7.3 Rest of Asia Pacific Thrombosis And Hemostasis Biomarkers Market by End-use
        • 8.3.6.7.4 Rest of Asia Pacific Thrombosis And Hemostasis Biomarkers Market by Location
        • 8.3.6.7.5 Rest of Asia Pacific Thrombosis And Hemostasis Biomarkers Market by Type
  • 8.4 LAMEA Thrombosis And Hemostasis Biomarkers Market
    • 8.4.1 LAMEA Thrombosis And Hemostasis Biomarkers Market by Product
      • 8.4.1.1 LAMEA Reagents & Consumables Market by Country
      • 8.4.1.2 LAMEA Analyzers Market by Country
    • 8.4.2 LAMEA Thrombosis And Hemostasis Biomarkers Market by Application
      • 8.4.2.1 LAMEA Deep Vein Thrombosis (DVT) Market by Country
      • 8.4.2.2 LAMEA Pulmonary Embolism (PE) Market by Country
      • 8.4.2.3 LAMEA Disseminated Intravascular Coagulation (DIC) & Others Market by Country
    • 8.4.3 LAMEA Thrombosis And Hemostasis Biomarkers Market by End-use
      • 8.4.3.1 LAMEA Diagnostic Centers Market by Country
      • 8.4.3.2 LAMEA Hospitals & Clinics Market by Country
      • 8.4.3.3 LAMEA Academic & Research Institutes and Others Market by Country
    • 8.4.4 LAMEA Thrombosis And Hemostasis Biomarkers Market by Location
      • 8.4.4.1 LAMEA Clinical Laboratory Tests Market by Country
      • 8.4.4.2 LAMEA Point-of-Care Tests Market by Country
    • 8.4.5 LAMEA Thrombosis And Hemostasis Biomarkers Market by Type
      • 8.4.5.1 LAMEA Post-Thrombin (PT) Market by Country
      • 8.4.5.2 LAMEA Activated Partial Thromboplastin Time (APTT) Test Market by Country
      • 8.4.5.3 LAMEA D-Dimer Market by Country
      • 8.4.5.4 LAMEA Anti-Thrombin III Market by Country
      • 8.4.5.5 LAMEA Plasminogen & Fibrinogen Market by Country
      • 8.4.5.6 LAMEA Soluble Fibrin Market by Country
      • 8.4.5.7 LAMEA Selectins Market by Country
      • 8.4.5.8 LAMEA Factor VIII Market by Country
      • 8.4.5.9 LAMEA Others Market by Country
    • 8.4.6 LAMEA Thrombosis And Hemostasis Biomarkers Market by Country
      • 8.4.6.1 Brazil Thrombosis And Hemostasis Biomarkers Market
        • 8.4.6.1.1 Brazil Thrombosis And Hemostasis Biomarkers Market by Product
        • 8.4.6.1.2 Brazil Thrombosis And Hemostasis Biomarkers Market by Application
        • 8.4.6.1.3 Brazil Thrombosis And Hemostasis Biomarkers Market by End-use
        • 8.4.6.1.4 Brazil Thrombosis And Hemostasis Biomarkers Market by Location
        • 8.4.6.1.5 Brazil Thrombosis And Hemostasis Biomarkers Market by Type
      • 8.4.6.2 Argentina Thrombosis And Hemostasis Biomarkers Market
        • 8.4.6.2.1 Argentina Thrombosis And Hemostasis Biomarkers Market by Product
        • 8.4.6.2.2 Argentina Thrombosis And Hemostasis Biomarkers Market by Application
        • 8.4.6.2.3 Argentina Thrombosis And Hemostasis Biomarkers Market by End-use
        • 8.4.6.2.4 Argentina Thrombosis And Hemostasis Biomarkers Market by Location
        • 8.4.6.2.5 Argentina Thrombosis And Hemostasis Biomarkers Market by Type
      • 8.4.6.3 UAE Thrombosis And Hemostasis Biomarkers Market
        • 8.4.6.3.1 UAE Thrombosis And Hemostasis Biomarkers Market by Product
        • 8.4.6.3.2 UAE Thrombosis And Hemostasis Biomarkers Market by Application
        • 8.4.6.3.3 UAE Thrombosis And Hemostasis Biomarkers Market by End-use
        • 8.4.6.3.4 UAE Thrombosis And Hemostasis Biomarkers Market by Location
        • 8.4.6.3.5 UAE Thrombosis And Hemostasis Biomarkers Market by Type
      • 8.4.6.4 Saudi Arabia Thrombosis And Hemostasis Biomarkers Market
        • 8.4.6.4.1 Saudi Arabia Thrombosis And Hemostasis Biomarkers Market by Product
        • 8.4.6.4.2 Saudi Arabia Thrombosis And Hemostasis Biomarkers Market by Application
        • 8.4.6.4.3 Saudi Arabia Thrombosis And Hemostasis Biomarkers Market by End-use
        • 8.4.6.4.4 Saudi Arabia Thrombosis And Hemostasis Biomarkers Market by Location
        • 8.4.6.4.5 Saudi Arabia Thrombosis And Hemostasis Biomarkers Market by Type
      • 8.4.6.5 South Africa Thrombosis And Hemostasis Biomarkers Market
        • 8.4.6.5.1 South Africa Thrombosis And Hemostasis Biomarkers Market by Product
        • 8.4.6.5.2 South Africa Thrombosis And Hemostasis Biomarkers Market by Application
        • 8.4.6.5.3 South Africa Thrombosis And Hemostasis Biomarkers Market by End-use
        • 8.4.6.5.4 South Africa Thrombosis And Hemostasis Biomarkers Market by Location
        • 8.4.6.5.5 South Africa Thrombosis And Hemostasis Biomarkers Market by Type
      • 8.4.6.6 Nigeria Thrombosis And Hemostasis Biomarkers Market
        • 8.4.6.6.1 Nigeria Thrombosis And Hemostasis Biomarkers Market by Product
        • 8.4.6.6.2 Nigeria Thrombosis And Hemostasis Biomarkers Market by Application
        • 8.4.6.6.3 Nigeria Thrombosis And Hemostasis Biomarkers Market by End-use
        • 8.4.6.6.4 Nigeria Thrombosis And Hemostasis Biomarkers Market by Location
        • 8.4.6.6.5 Nigeria Thrombosis And Hemostasis Biomarkers Market by Type
      • 8.4.6.7 Rest of LAMEA Thrombosis And Hemostasis Biomarkers Market
        • 8.4.6.7.1 Rest of LAMEA Thrombosis And Hemostasis Biomarkers Market by Product
        • 8.4.6.7.2 Rest of LAMEA Thrombosis And Hemostasis Biomarkers Market by Application
        • 8.4.6.7.3 Rest of LAMEA Thrombosis And Hemostasis Biomarkers Market by End-use
        • 8.4.6.7.4 Rest of LAMEA Thrombosis And Hemostasis Biomarkers Market by Location
        • 8.4.6.7.5 Rest of LAMEA Thrombosis And Hemostasis Biomarkers Market by Type

Chapter 9. Company Profiles

  • 9.1 Thermo Fisher Scientific, Inc.
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Segmental and Regional Analysis
    • 9.1.4 Research & Development Expenses
    • 9.1.5 SWOT Analysis
  • 9.2 F. Hoffmann-La Roche Ltd.
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Segmental and Regional Analysis
    • 9.2.4 Research & Development Expense
  • 9.3 Siemens Healthineers AG (Siemens AG)
    • 9.3.1 Company Overview
    • 9.3.2 Financial Analysis
    • 9.3.3 Segmental and Regional Analysis
    • 9.3.4 Research & Development Expense
    • 9.3.5 Recent strategies and developments:
      • 9.3.5.1 Product Launches and Product Expansions:
    • 9.3.6 SWOT Analysis
  • 9.4 Abbott Laboratories
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Segmental and Regional Analysis
    • 9.4.4 Research & Development Expense
    • 9.4.5 SWOT Analysis
  • 9.5 BioMerieux S.A.
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Segmental and Regional Analysis
    • 9.5.4 Research & Development Expenses
  • 9.6 Horiba Ltd.
    • 9.6.1 Company Overview
    • 9.6.2 Financial Analysis
    • 9.6.3 Regional & Segmental Analysis
    • 9.6.4 Research & Development Expenses
    • 9.6.5 Recent strategies and developments:
      • 9.6.5.1 Product Launches and Product Expansions:
  • 9.7 QuidelOrtho Corporation
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Regional Analysis
    • 9.7.4 Research & Development Expense
  • 9.8 Werfen, S.A.
    • 9.8.1 Company Overview
  • 9.9 Diazyme Laboratories, Inc. (General Atomics)
    • 9.9.1 Company Overview
  • 9.10. BioMedica Diagnostics Inc. (Scotia Investments Family of Companies)
    • 9.10.1 Company Overview